FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11179211000001103: Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40402701000001116 Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
40402801000001113 Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Is a Co-careldopa 50mg/200mg modified-release tablets 60 tablet true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Is pack of Caramet 50mg/200mg CR tablets (Teva UK Ltd) false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has AMP Caramet 50mg/200mg CR tablets (Teva UK Ltd) true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) 60 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start